| HOME >> BIOLOGY >> TECHNOLOGY |
ended June 30, to June 30,
2007 2006 2007
---------- ---------- ----------
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of share capital - net of share
issuance expenses -- 24,391 128,734
Exercise of share warrants and stock
options 3 92 2,103
Proceeds from long-term debt -- -- 399
Proceeds from short-term debt -- -- 50
Repayment of long-term debt -- -- (399)
Repayment of short-term debt -- -- (50)
--------- --------- ---------
Net cash provided by financing activities 3 24,483 130,837
--------- --------- ---------
NET INCREASE (DECREASE) IN CASH AND
CASH EQUIVALENTS (1,949) 18,812 2,451
BALANCE OF CASH AND CASH EQUIVALENTS AT
BEGINNING OF PERIOD 4,400 13,360 --
--------- --------- ---------
BALANCE OF CASH AND CASH EQUIVALENTS AT
END OF PERIOD 2,451 32,172 2,451
======== ========= =========
Supplementary information on investing
and financing activities not involving
cash flows -
Issuance of ordinary shares in respect of
license, and purchase of assets -- -- 1,391
Conversion of convertible subordinated
Debenture into shares
'/>"/>
SOURCE XTL Biopharmaceuticals Ltd![]() Copyright©2007 PR Newswire. |